Published on February 4, 2022Citation: Vaccines Are Not Cost-Effective, Vaccinations Are, Health Affairs Forefront, February 4, 2022. DOI: 10.1377/forefront.20220202.717744Journal: Health Affairs ForefrontRead Publication
Published on February 4, 2022Citation: Why So Few Value Assessments On Health Services And Procedures, And What Should Be Done?, Health Affairs Forefront, February 4, 2022. Journal: Health Affairs ForefrontRead Publication
Published on January 26, 2022Citation: The Certainty Of Uncertainty In Health Technology Assessment, Health Affairs Forefront, January 26, 2022. DOI: 10.1377/forefront.20220125.37540Journal: Health Affairs ForefrontRead Publication
Published on January 25, 2022Citation: Medicare’s Aducanumab Decision Highlights Needed Reforms To FDA And CMS Regulatory Pathways, Health Affairs Forefront, January 25, 2022. DOI: 10.1377/forefront.20220121.566837 Journal: Health Affairs ForefrontRead Publication
Published on January 10, 2022Citation: Ma, S., Lavelle, T.A., Ollendorf, D.A. et al. Herd Immunity Effects in Cost-Effectiveness Analyses among Low- and Middle-Income Countries. Appl Health Econ Health Policy (2022). https://doi.org/10.1007/s40258-021-00711-yJournal: Applied Health Economics and Health PolicyRead Publication
Published on December 2, 2021Citation: Lenahan K, Panzer AD, Gertler R, Chambers JD. Use of prescriber requirements among US commercial health plans. J Manag Care Spec Pharm. 2021 Dec;27(12):1757-1762. doi: 10.18553/jmcp.2021.27.12.1757. PMID: 34818091.Journal: Journal of Managed Care & Specialty PharmacyRead Publication
Published on November 25, 2021Citation: Chambers, J.D., Silver, M.C., Berklein, F.C. et al. Are Medical Devices Cost-Effective?. Appl Health Econ Health Policy (2021). https://doi.org/10.1007/s40258-021-00698-6Journal: Applied Health Economics and Health PolicyRead Publication
Published on November 13, 2021Citation: Neumann PJ, Cohen JT, Ollendorf DA. Drug-Pricing Debate Redux - Should Cost-Effectiveness Analysis Be Used Now to Price Pharmaceuticals? N Engl J Med. 2021 Nov 13. doi: 10.1056/NEJMp2113323. Journal: New England Journal of MedicineRead Publication
Published on November 12, 2021Citation: Neumann PJ, Podolsky MI, Basu A, Ollendorf DA, Cohen JT, Do Cost-Effectiveness Analyses Account for Drug Genericization? A Literature Review and Assessment of Implications. Value in Health, 2021Journal: Value in HealthRead Publication
Published on November 8, 2021Citation: Tunis S, Hanna E, Neumann P, Toumi M, Drummond M, Fricke F, Sullivan SD, Malone DC, Persson U, Chambers JD, Variation in market access decisions for cell and gene therapies across the United States, Canada, and Europe, Health Policy, 2021.Journal: Health PolicyRead Publication